ArticleBlood2015

OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.

Ta-Ming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.